MRMD improved its adjusted EBITDA in Q1 2019 by 76 percent The company’s multipronged strategy for growth includes continued consolidation of cannabis operations and the launch of a subsidiary MariMed CEO identified the company as a “significant early mover” in the burgeoning CBD health and wellness market MariMed Inc. (OTCQB: MRMD) recorded a 69 percent […]

Endonovo’s flagship product, SofPulse, is an easy-to-place, non-invasive device delivering pulsed electromagnetic frequencies to enhance post-surgical recovery The company’s agreement with Veterans Healthcare Supply Solutions Inc. includes distribution of SofPulse to Veterans Administration facilities and Department of Defense health care facilities Treatment with SofPulse allows patients to better manage post-operative pain without the adverse side […]

Nabis Holdings discussed the importance of cannabis legislative changes during an inaugural edition of a congressional cannabis forum in Washington, DC The company also announced the acquisition of a cannabis extraction and production facility in Washington state Through modernization and expansion, the company plans to ramp up the facility’s production capacity to 20,500 kilograms per […]

Geyser Brands recently commenced upgrades; it anticipates R&D and processing amendments The facility expansion is expected to improve the company’s focus on processing quality and consumer satisfaction Solace Management Group recently increased its production capacity and invested in new equipment for consumer health care and pet wellness production Geyser Brands Inc. (TSX.V: GYSR) is a […]

Long-term agreement signed with Veterans Healthcare Supply Solutions Inc. to directly distribute SofPulse devices to Veterans Administration Facilities and Department of Defense Healthcare Facilities Partnership with SunMED Medical Solutions, one of the premier medical equipment distributors and claim experts in the U.S., expands Endonovo’s distribution capabilities and expands ability of providers, facilities and patients to […]

INmune Bio is a diversified, clinical stage immunology company developing novel therapies targeting distinct parts of a patient’s innate immune system to fight disease Drug candidates INKmune and INB03 may be used to treat cancer; XPro1595 targets neuroinflammation as a cause of Alzheimer’s disease The company was awarded a $1 million “Part the Cloud” grant […]

The global hemp cannabidiol market is expected to top $22 billion worldwide by 2022, with CBD products comprising 25 percent of all cannabis sales Wildflower Brands is expanding the wellness reach of its cannabis products through a distribution pact with South African cannabis network provider Africann The company is also launching into Europe with a […]

Genprex, a clinical stage gene therapy company, will be utilizing the services of a leading pharmaceutical branding agency to oversee the naming process of its lead drug candidate, Oncoprex Addison Whitney has over 28 years of experience in the market, guiding pharmaceutical companies such as Merck, Celgene and Roche through the regulatory steps involved in […]

Beyond Meat’s financial results will be announced during a conference call scheduled for June 6 A live webcast will also be available via the company’s official website for investors interested in the financial information Beyond Meat’s portfolio of plant-based foods that replicate the taste and texture of meat has grown in popularity since the company’s […]

INmune Bio’s IPO closed February 1, 2019, with NASDAQ Capital Markets listing on February 4, 2019 Public clinical-stage immunology company with programs in oncology and neurodegenerative disease INmune Bio targets large markets with unsolved problems such as resistance to checkpoint inhibitor therapy, a fast-growing oncology market segment; MRD, the cause of cancer relapse; and neuroinflammation […]